LUNG CANCER SQUAMOUS CELL

Clinical trials for LUNG CANCER SQUAMOUS CELL explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER SQUAMOUS CELL trials appear

Sign up with your email to follow new studies for LUNG CANCER SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Double-Drug attack on tough cancers

Disease control Terminated

This early-stage study is testing the safety of combining two experimental drugs, palbociclib and gedatolisib, for people with advanced cancers that have stopped responding to standard treatments. The main goal is to find the highest dose of this drug combination that patients ca…

Matched conditions: LUNG CANCER SQUAMOUS CELL

Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

LUNG CANCER SQUAMOUS CELL

Get alerted when new LUNG CANCER SQUAMOUS CELL trials appear

Scientists test Double-Drug attack on tough cancers